Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial

Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record for the emraclidine schizophrenia study is now available, with study design, eligibility criteria, outcomes, locations, and posted results information.
    Difference
    83%
    Check dated 2026-11-07T12:23:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:25:19.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears at the top of the page, announcing a website transition and explaining the terminology change from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T12:55:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:58:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from `v3.7.0` to `v3.7.1` while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:43:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. The detailed trial information and related sections appear to be removed or hidden, leaving a simple error page with a Home link.
    Difference
    17%
    Check dated 2026-09-19T19:17:59.000Z thumbnail image

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.